ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
ResMed (RMD) Tops Q1 EPS by 2c, Revenues Beat
October 25, 2018 4:14 PM EDTResMed (NYSE: RMD) reported Q1 EPS of $0.81, $0.02 better than the analyst estimate of $0.79. Revenue for the quarter came in at $588.3 million versus the consensus estimate of $571.29 million.
Revenue increased 12% to $588.3 million; up 13% on a constant currency basisNet income increased by 23%;... More


